Figure 3.
Inhibition of bFGF-mediated angiogenesis in the CAM model by 4 μg/20 μL/CAM of ajoene (8), allicin (1), difluoroalliicin 12, and S-2-fluoro-2-propenyl-l-cysteine (13); * p < 0.01 difluoroallicin (12) versus allicin (1) and ** p < 0.001 for all versus control FGF. Data showed that all organosulfur compounds tested demonstrated significant anti-angiogenesis activity, with greater efficacy for difluoroallicin 12 versus allicin (1). Data represent Mean (% inhibition of angiogenesis) ± SEM, n = 6–8 CAM/group.
